In animal dosing experiments, smaller rhGH particles in microcapsules decreased initial in vivo release.
In plain wordsIn animals, smaller growth hormone particles in microcapsules decreased initial release compared with larger particles.
- Peptide
- HGH (somatotropin)
- Outcome
- DecreaseInitial release
- Study
ratn: not reported in source
- Comparator
- larger rhGH particle size
- Outcome group
- Pharmacokinetics · Pharmacology
- Studied dose
- Dose not stated · subcutaneousAs given in this study (rat).
Source sentences
As the particle size of rhGH decreased, the in vivo initial release decreased, while subsequent serum levels of rhGH in sustained release phase were higher.
2 context sentences(design, population, supporting numbers)
Addition of zinc oxide to microcapsules resulted in higher serum levels than those prepared without zinc oxide, suggesting a stabilizing effect of zinc oxide after subcutaneous injection into rats.
Biodegradable microcapsules for sustained release of recombinant human growth hormone (rhGH) were prepared by a solid-in-oil-in-water (S/O/W) emulsion solvent evaporation technique using lyophilized protein microparticles.